The Technology team advised Zus Health on the launch and completion of its $34 million Series A financing led by Andreessen Horowitz (a16z). F-Prime Capital, Maverick Ventures, Rock Health, Martin Ventures and Oxeon Investments also participated in the round.
Zus will use the funding to grow its engineering team and invest in the platform, tools and products that support the digital-first healthcare builders with whom Zus partners. The company launches with four builders on its platform including Cityblock Health, Dorsata, Firefly Health and Oak Street Health. The builders will start to use Zus as an “information sidecar” and then proceed to build proprietary apps for consumption and sale over time.
Creating the industry’s first shared development platform backed by a shared data record, Zus aims to bring about a better health data reality by empowering a wave of new, digital-first healthcare builders who will create digital health technologies and services that are cheaper, more customizable and more personalized.
The Goodwin team was led by David Cappillo, Paul Rosie and Katherine Hand.
For additional details on the financing round, please read the press release.
Zus will use the funding to grow its engineering team and invest in the platform, tools and products that support the digital-first healthcare builders with whom Zus partners. The company launches with four builders on its platform including Cityblock Health, Dorsata, Firefly Health and Oak Street Health. The builders will start to use Zus as an “information sidecar” and then proceed to build proprietary apps for consumption and sale over time.
Creating the industry’s first shared development platform backed by a shared data record, Zus aims to bring about a better health data reality by empowering a wave of new, digital-first healthcare builders who will create digital health technologies and services that are cheaper, more customizable and more personalized.
The Goodwin team was led by David Cappillo, Paul Rosie and Katherine Hand.
For additional details on the financing round, please read the press release.